# Boostrix® Pregnancy Registry

> **NCT02096276** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1517 (actual)

## Conditions studied

- Pertussis

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT02096276
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-31
- **Primary completion:** 2019-08-02
- **Final completion:** 2019-08-02
- **Target enrollment:** 1517 (ACTUAL)
- **Last updated:** 2020-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02096276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02096276, "Boostrix® Pregnancy Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02096276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*